SQI Diagnostics Inc.
SQIDF · OTC
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $1 | $1 |
| % Growth | -27.6% | -70.8% | -2.8% | – |
| Cost of Goods Sold | $0 | $0 | $2 | $1 |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | 51.6% | 27.1% | -27.8% | 35.7% |
| R&D Expenses | $0 | $1 | $2 | $2 |
| G&A Expenses | $1 | $1 | $0 | $2 |
| SG&A Expenses | $1 | $1 | $1 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $3 | $4 | $5 |
| Operating Income | -$4 | -$3 | -$6 | -$4 |
| % Margin | -1,565% | -768.9% | -505.2% | -338.6% |
| Other Income/Exp. Net | $0 | -$1 | -$19 | -$1 |
| Pre-Tax Income | -$4 | -$4 | -$8 | -$5 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4 | -$4 | -$8 | -$5 |
| % Margin | -1,396.1% | -1,095.4% | -655.6% | -372.5% |
| EPS | -0.009 | -0.01 | -0.02 | -0.012 |
| % Growth | 10.3% | 51.5% | -70.9% | – |
| EPS Diluted | -0.009 | -0.01 | -0.02 | -0.012 |
| Weighted Avg Shares Out | 406 | 398 | 394 | 394 |
| Weighted Avg Shares Out Dil | 406 | 398 | 394 | 394 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $2 | $0 |
| Depreciation & Amortization | $0 | $0 | $2 | $1 |
| EBITDA | -$2 | -$2 | -$4 | -$3 |
| % Margin | -622.8% | -702% | -368.3% | -228.4% |